Clinical Researcher Debarments Proceeding Slowly, Despite FDA Promises Of Reform
This article was originally published in The Pink Sheet Daily
Executive Summary
It still takes years to debar a physician convicted of a crime from conducting clinical research.
You may also be interested in...
FDA’s Rulemaking To-Do List Includes Clarifying Citizen Petitions And Orphan Drug Designations
FDA pending actions include proposed rules on the handling of citizen petitions, eligibility for orphan drug designation and post-market safety reporting for combination products.
FDA Will Revise Investigator Disqualification Regs In Response To GAO Report
The agency will revise its regulations to prevent clinical investigators who are disqualified from running trials for one product type to continue leading studies for other FDA-regulated categories.
FDA Will Move Faster To Ban Bad Actors From Clinical Trials
Recent changes will speed FDA's process for barring non-compliant clinical trial investigators from future product research, agency staffers say